Trial Profile

A Phase 1 Study to Evaluate the Pharmacokinetics of Single and Multiple Doses of AM0010 in Healthy Adult Subjects

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 08 Apr 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Ilodecakin (Primary)
Indications Breast cancer; Colorectal cancer; Fibrosis; Hypercholesterolaemia; Inflammatory bowel diseases; Malignant melanoma; Non-small cell lung cancer; Ovarian cancer; Pancreatic cancer; Prostate cancer; Renal cancer
Focus Pharmacokinetics
Acronyms Willow 1
Sponsors Eli Lilly and Company (India) Pvt. Ltd

Most Recent Events

18 Dec 2017 Status changed from active, no longer recruiting to completed.
23 Oct 2017 Status changed from recruiting to active, no longer recruiting.
05 Sep 2017 Status changed from not yet recruiting to recruiting.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com